Found 7 matching trials
PTC299 for Treatment of Neurofibromatosis Type 2
PHASE2Formation of new blood vessels (angiogenesis) is important for tumor growth...
Location
Massachusetts General Hospital
Study of PTC299 (Emvododstat) in Relapsed/Refractory Acute Leukemias
PHASE1This is an open-label, non-randomized, Phase 1b study to evaluate the safet...
Location
Rocky Mountain Cancer Center
PTC299 and Hormonal Agent for Treatment of Metastatic Breast Cancer
PHASE1Formation of new blood vessels (angiogenesis) is important for tumor growth...
Location
Indiana University Simon Cancer Center
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
PHASE1RATIONALE: PTC299 may stop the growth of tumor cells by blocking blood flow...
Location
UCSF Cancer Center and Cancer Research Institute
A Study to Evaluate Efficacy and Safety of PTC299 (Emvododstat) in Hospitalized Participants With Coronavirus (COVID-19)
PHASE2This is a randomized, double-blind, placebo-controlled, multicenter, 28-day...
Location
University of California, Irvine
PTC299 for Treatment of Advanced Cancer
PHASE1Formation of new blood vessels (angiogenesis) is important for tumor growth...
Location
Memorial Sloan-Kettering Cancer Center
PTC299 in Treating Patients With HIV-Related Kaposi Sarcoma
PHASE1RATIONALE: PTC299 may stop the growth of Kaposi sarcoma by blocking blood f...
Location
Rebecca and John Moores UCSD Cancer Center